Yizhen Li

9PUBLICATIONS
56CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NeurogeneticsDevelopmental genetics (incl. sex determination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 02, 2026
Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

|Apr 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic Leukemia.

|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin.

Carolin S Escherich, Zhenhua Li, Kelly R Barnett

|Jan 10, 2025
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.

Carolin S Escherich, Takaya Moriyama, Zhenhua Li

|Nov 19, 2024
Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models.

Sankaranarayanan Kannan, Yizhen Li, Natalia Baran

|Mar 06, 2024
Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.

Carolin S Escherich, Wenan Chen, Yizhen Li

Pageof 2

Frequent Collaborators

7 joint publications

Jiyang Yu

6 joint publications

Wenjian Yang

5 joint publications

Ching-Hon Pui

4 joint publications

Jun J Yang